Who Owns Akari Therapeutics Stock?
NASDAQ: AKTXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 10.42%
- Held by insiders
- 13.25%
- Institutional holders
- 12
- Institutions 10.4%
- Insiders 13.3%
- Public and other 76.3%
Who owns Akari Therapeutics stock?
Institutional investors own about 10.4% of Akari Therapeutics's shares, spread across 12 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.25% of AKTX.
The largest institutional holders are MMCAP International, Inc. SPC (5.14%), Cresset Asset Management, LLC (1.06%) and Jane Street Group, LLC (0.79%). Together, the top 9 institutions control 7.7% of shares outstanding. In their latest filings, 6 of the top 9 institutions increased their AKTX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AKTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| MMCAP International, Inc. SPC | 100.00K | 5.14% | +100.0% |
| Cresset Asset Management, LLC | 20.56K | 1.06% | 0.0% |
| Jane Street Group, LLC | 15.46K | 0.79% | +100.0% |
| HRT Financial LP | 13.74K | 0.71% | +100.0% |
| IFP Advisors, Inc | 181 | 0.01% | -50.0% |
| SBI Securities Co., Ltd. | 14 | 0.00% | +180.0% |
| Caitong International Asset Management Co., Ltd | 8 | 0.00% | +100.0% |
| Northwestern Mutual Wealth Management Company | 7 | 0.00% | +100.0% |
| Truvestments Capital, LLC | 1 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AKTX
| Fund | Shares | % Held |
|---|---|---|
| RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc | 13 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Akari Therapeutics?
MMCAP International, Inc. SPC is the largest institutional shareholder of AKTX, owning 5.14% of shares outstanding (100.00K shares) as of its latest 13F filing.
What percentage of Akari Therapeutics is owned by institutions?
Institutions own about 10.4% of AKTX shares and 12.0% of the public float.
How much of Akari Therapeutics do insiders own?
Insiders, such as officers and directors, own about 13.25% of AKTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.